152 related articles for article (PubMed ID: 18837736)
1. Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus.
Garrido-Sánchez L; Cardona F; García-Fuentes E; Rojo-Martínez G; Gómez-Zumaquero JM; Picón MJ; Soriguer F; Tinahones FJ
Eur J Clin Invest; 2008 Sep; 38(9):615-21. PubMed ID: 18837736
[TBL] [Abstract][Full Text] [Related]
2. Reduced levels of anti-MDA LDL antibodies in patients with carbohydrate metabolism disorders.
Garrido-Sánchez L; García-Pinilla JM; Jiménez-Navarro M; Fernández-Pastora J; Alonso-Briales JH; Hernández-Garcia JM; De-Teresa-Galván E; Tinahones FJ
Clin Lab; 2011; 57(11-12):901-7. PubMed ID: 22239020
[TBL] [Abstract][Full Text] [Related]
3. Anti-oxidized LDL antibody levels are reduced in women with hypertension.
Garrido-Sánchez L; García-Fuentes E; Cardona F; Rojo-Martínez G; Soriguer F; Tinahones FJ
Eur J Clin Invest; 2009 Sep; 39(9):800-6. PubMed ID: 19674079
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
5. Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris.
Doo YC; Han SJ; Lee JH; Cho GY; Hong KS; Han KR; Lee NH; Oh DJ; Ryu KH; Rhim CY; Lee KH; Lee Y
Am J Cardiol; 2004 Mar; 93(5):554-8. PubMed ID: 14996578
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
7. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study.
Guerrero-Romero F; Rascón-Pacheco RA; Rodríguez-Morán M; de la Peña JE; Wacher N
Eur J Clin Invest; 2008 Jun; 38(6):389-96. PubMed ID: 18489400
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
[TBL] [Abstract][Full Text] [Related]
10. Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up.
Alvarsson M; Hilding A; Ostenson CG
Diabet Med; 2009 Apr; 26(4):345-53. PubMed ID: 19388963
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
Dotevall A; Hulthe J; Rosengren A; Wiklund O; Wilhelmsen L
Clin Sci (Lond); 2001 Nov; 101(5):523-31. PubMed ID: 11672458
[TBL] [Abstract][Full Text] [Related]
12. Baseline diene conjugation in LDL lipids from newly diagnosed type 2 diabetic patients.
Gavella M; Lipovac V; Car A; Vucic M
Diabetes Metab; 2002 Nov; 28(5):391-6. PubMed ID: 12461476
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and characteristics of impaired glucose metabolism in patients referred to comprehensive cardiac rehabilitation: the DANSUK study.
Boas Soja AM; Zwisler AD; Melchior T; Hommel E; Torp-Pedersen C; Madsen M
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):784-90. PubMed ID: 17001219
[TBL] [Abstract][Full Text] [Related]
14. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.
Tso AW; Xu A; Sham PC; Wat NM; Wang Y; Fong CH; Cheung BM; Janus ED; Lam KS
Diabetes Care; 2007 Oct; 30(10):2667-72. PubMed ID: 17620449
[TBL] [Abstract][Full Text] [Related]
15. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance.
Kajiyama S; Hasegawa G; Asano M; Hosoda H; Fukui M; Nakamura N; Kitawaki J; Imai S; Nakano K; Ohta M; Adachi T; Obayashi H; Yoshikawa T
Nutr Res; 2008 Mar; 28(3):137-43. PubMed ID: 19083400
[TBL] [Abstract][Full Text] [Related]
16. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
[TBL] [Abstract][Full Text] [Related]
17. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance.
Xiang GD; Sun HL; Zhao LS; Hou J; Yue L; Xu L
Clin Endocrinol (Oxf); 2008 May; 68(5):716-23. PubMed ID: 18070144
[TBL] [Abstract][Full Text] [Related]
18. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
19. Incidence of type 2 diabetes in southern Spain (Pizarra Study).
Soriguer F; Rojo-Martínez G; Almaraz MC; Esteva I; Ruiz de Adana MS; Morcillo S; Valdés S; García-Fuentes E; García-Escobar E; Cardona I; Gomez-Zumaquero JM; Olveira-Fuster G
Eur J Clin Invest; 2008 Feb; 38(2):126-33. PubMed ID: 18226046
[TBL] [Abstract][Full Text] [Related]
20. Reduced attenuation of bone resorption after oral glucose in type 2 diabetes.
Chailurkit LO; Chanprasertyothin S; Rajatanavin R; Ongphiphadhanakul B
Clin Endocrinol (Oxf); 2008 Jun; 68(6):858-62. PubMed ID: 18088395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
